The Effect of Potatoes on Markers of Cardiometabolic Health

Completed · Not applicable

Conditions studied: Type 2 Diabetes Mellitus, Cardiovascular Diseases

In brief

A 2-period randomized cross-over trial will be conducted to determine the effect of incorporating 1 medium size potato, compared to an isocaloric portion of refined grains, on fasting glucose levels, insulin sensitivity, blood pressure, lipids and lipoproteins, arterial stiffness, body weight, gut microbiome, and dietary intake.

Key facts

Study ID

NCT03495284

Run by

Penn State University

People needed

51

Starts

2018-02-19

Expected to finish

2020-01-19

Last updated by the study team

2023-08-18

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Non-smoking
• BMI > 20 and <40 kg/m2
• Male or female

You may not qualify if…

• Diagnosed diabetes or fasting glucose >126 mg/dl
• Hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
• Prescribed anti-hypertensive, lipid lowering or glucose lowering drugs
• Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease or inflammatory conditions
• Use of supplements (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals and not willing to cease for the duration of the study
• Pregnancy or lactation
• Weight loss of >=10% of body weight within the 6 months prior to enrolling in the study
• Smoking or use of any tobacco products

Where it is running

• Pennsylvania State University — University Park, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.